Monday Takeaways: The Number to Watch This Week
Was last week’s late stage rally a sign of things to come… these crucial numbers have the answer.
Dealmaker’s Diary: Shining a Light on a High-Wattage Dividend Payer
Alpesh is flipping the script with this dividend-paying utility that’s concentrated in the Pacific Northwest…
Buy This, Not That: A Big Dose of 5 Big Pharma Stocks
Which of these five drugmakers stocks hands out a prescription for portfolio health?
Monday Takeaways: A Perfect Storm of Politics, Earnings, and Economic Data
Tech stocks took a beating last week… the markets jumped in early Monday trading… and some big data awaits. Here’s what’s affecting your money this week…
Dealmaker’s Diary: Get Paid to Play the Stock Market
This dividend-paying asset manager is ready for a breakout to its former all-time high.
Buy This, Not That: Are the Big Banks Big Buys?
While the big banks are touting impressive headline numbers, with record highs and substantial profit increases, there’s something lurking under the surface…
Monday Takeaways: Bank on Trouble Coming
Forget the back-to-back-to-back market highs. The latest bank earnings reports are a warning…
Dealmaker’s Diary: Add This Undervalued Retail Pioneer to Your Cart
This bulk retail pioneer has been serving up jumbo-sized gains over the past few years. Get the ticker here.
Buy This, Not That: Put These Controversial Stocks on Your “Buy” List
It doesn’t matter what they do or where they do it. Are they making money? These five Chinese stocks are.
Monday Takeaways: The Magnificent Seven’s Creative Destruction
Barron’s is out with a piece that suggests it’s time to get out of the Magnificent Seven. Here’s why that’s wrong.